$ACOR Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ACORDA THERAPEUTICS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in ACORDA THERAPEUTICS INC. Get notifications about new insider transactions in ACORDA THERAPEUTICS INC for free.
Page: < prev 1 2 3 4 5 6 7 8 ... 17 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 12 2015 | ACOR | ACORDA THERAPEUTIC ... | Carrazana Enrique J. | Chief Medical Offic ... | Sell | S | 42.61 | 8,200 | 349,400 | 38,665 | 46.9 K to 38.7 K (-17.50 %) |
Jan 12 2015 | ACOR | ACORDA THERAPEUTIC ... | Carrazana Enrique J. | Chief Medical Offic ... | Buy | M | 21.52 | 13,371 | 287,744 | 46,865 | 33.5 K to 46.9 K (+39.92 %) |
Jan 12 2015 | ACOR | ACORDA THERAPEUTIC ... | Carrazana Enrique J. | Chief Medical Offic ... | Sell | S | 42.11 | 77,907 | 3,280,337 | 33,494 | 111.4 K to 33.5 K (-69.93 %) |
Jan 12 2015 | ACOR | ACORDA THERAPEUTIC ... | Carrazana Enrique J. | Chief Medical Offic ... | Buy | M | 21.52 | 42,879 | 922,756 | 111,401 | 68.5 K to 111.4 K (+62.58 %) |
Jan 12 2015 | ACOR | ACORDA THERAPEUTIC ... | Carrazana Enrique J. | Chief Medical Offic ... | Buy | M | 26.35 | 18,225 | 480,229 | 68,522 | 50.3 K to 68.5 K (+36.23 %) |
Jan 12 2015 | ACOR | ACORDA THERAPEUTIC ... | Carrazana Enrique J. | Chief Medical Offic ... | Buy | M | 30.46 | 16,803 | 511,819 | 50,297 | 33.5 K to 50.3 K (+50.17 %) |
Jan 12 2015 | ACOR | ACORDA THERAPEUTIC ... | Carrazana Enrique J. | Chief Medical Offic ... | Sell | S | 42.01 | 6,715 | 282,069 | 33,494 | 40.2 K to 33.5 K (-16.70 %) |
Jan 12 2015 | ACOR | ACORDA THERAPEUTIC ... | Carrazana Enrique J. | Chief Medical Offic ... | Buy | M | 30.46 | 6,715 | 204,539 | 40,209 | 33.5 K to 40.2 K (+20.05 %) |
Dec 31 2014 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | President, Intl and ... | Option Exercise | M | 41.07 | 10,000 | 410,700 | 10,000 | |
Dec 31 2014 | ACOR | ACORDA THERAPEUTIC ... | ROGERS MICHAEL W | Chief Financial Off ... | Option Exercise | M | 41.07 | 15,000 | 616,050 | 15,000 | |
Dec 31 2014 | ACOR | ACORDA THERAPEUTIC ... | Hindman Andrew A. | Chief Business Dev. ... | Option Exercise | M | 41.07 | 25,000 | 1,026,750 | 25,000 | |
Dec 22 2014 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief of Business O ... | Option Exercise | M | 8.14 | 27,109 | 220,667 | 0 | |
Dec 22 2014 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief of Business O ... | Sell | S | 40.11 | 27,109 | 1,087,399 | 11,046 | 38.2 K to 11 K (-71.05 %) |
Dec 22 2014 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief of Business O ... | Buy | M | 8.14 | 27,109 | 220,667 | 38,155 | 11 K to 38.2 K (+245.42 %) |
Dec 22 2014 | ACOR | ACORDA THERAPEUTIC ... | Kelley John P | Director | Option Exercise | M | 16.74 | 10,000 | 167,400 | 0 | |
Dec 22 2014 | ACOR | ACORDA THERAPEUTIC ... | Kelley John P | Director | Sell | S | 40.00 | 10,000 | 400,000 | 0 | 10 K to 0 (-100.00 %) |
Dec 22 2014 | ACOR | ACORDA THERAPEUTIC ... | Kelley John P | Director | Buy | M | 16.74 | 10,000 | 167,400 | 10,000 | 0 to 10 K |
Dec 16 2014 | ACOR | ACORDA THERAPEUTIC ... | PANEM SANDRA PHD | Director | Option Exercise | M | 31.61 | 10,000 | 316,100 | 0 | |
Dec 16 2014 | ACOR | ACORDA THERAPEUTIC ... | PANEM SANDRA PHD | Director | Sell | S | 38.10 | 10,000 | 381,000 | 2,912 | 12.9 K to 2.9 K (-77.45 %) |
Dec 16 2014 | ACOR | ACORDA THERAPEUTIC ... | PANEM SANDRA PHD | Director | Buy | M | 31.61 | 10,000 | 316,100 | 12,912 | 2.9 K to 12.9 K (+343.41 %) |
Dec 03 2014 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Option Exercise | M | 8.14 | 51,265 | 417,297 | 0 | |
Dec 03 2014 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 35.59 | 34,394 | 1,224,144 | 495,400 | 529.8 K to 495.4 K (-6.49 %) |
Dec 03 2014 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Buy | M | 8.14 | 51,265 | 417,297 | 529,794 | 478.5 K to 529.8 K (+10.71 %) |
Dec 03 2014 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief of Business O ... | Sell | S | 35.60 | 8,898 | 316,763 | 11,046 | 19.9 K to 11 K (-44.61 %) |
Dec 03 2014 | ACOR | ACORDA THERAPEUTIC ... | ROGERS MICHAEL W | Chief Financial Off ... | Sell | S | 35.58 | 230 | 8,183 | 41,505 | 41.7 K to 41.5 K (-0.55 %) |
Dec 03 2014 | ACOR | ACORDA THERAPEUTIC ... | Sabella Lauren M | Exec. VP-Commercial ... | Sell | S | 35.58 | 3,242 | 115,344 | 15,161 | 18.4 K to 15.2 K (-17.62 %) |
Dec 03 2014 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | President, Intl and ... | Sell | S | 35.58 | 6,956 | 247,471 | 94,578 | 101.5 K to 94.6 K (-6.85 %) |
Dec 03 2014 | ACOR | ACORDA THERAPEUTIC ... | Carrazana Enrique J. | Chief Medical Offic ... | Sell | S | 35.55 | 2,300 | 81,774 | 33,494 | 35.8 K to 33.5 K (-6.43 %) |
Nov 05 2014 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | President, Intl and ... | Option Exercise | M | 8.14 | 14,923 | 121,473 | 0 | |
Nov 05 2014 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | President, Intl and ... | Sell | S | 34.84 | 14,923 | 519,949 | 101,534 | 116.5 K to 101.5 K (-12.81 %) |
Nov 05 2014 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | President, Intl and ... | Buy | M | 8.14 | 14,923 | 121,473 | 116,457 | 101.5 K to 116.5 K (+14.70 %) |
Oct 22 2014 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientifc Off ... | Option Exercise | M | 8.14 | 52,338 | 426,031 | 0 | |
Oct 22 2014 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientifc Off ... | Sell | S | 32.08 | 52,338 | 1,678,788 | 65,787 | 118.1 K to 65.8 K (-44.31 %) |
Oct 22 2014 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientifc Off ... | Buy | M | 8.14 | 52,338 | 426,031 | 118,125 | 65.8 K to 118.1 K (+79.56 %) |
Oct 17 2014 | ACOR | ACORDA THERAPEUTIC ... | Carrazana Enrique J. | Chief Medical Offic ... | Sell | S | 31.67 | 933 | 29,546 | 35,794 | 36.7 K to 35.8 K (-2.54 %) |
Oct 17 2014 | ACOR | ACORDA THERAPEUTIC ... | Carrazana Enrique J. | Chief Medical Offic ... | Sell | S | 30.59 | 2,400 | 73,412 | 36,727 | 39.1 K to 36.7 K (-6.13 %) |
Oct 09 2014 | ACOR | ACORDA THERAPEUTIC ... | ROGERS MICHAEL W | Chief Financial Off ... | Sell | S | 33.10 | 5,700 | 188,660 | 41,735 | 47.4 K to 41.7 K (-12.02 %) |
Oct 09 2014 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief of Business O ... | Sell | S | 33.60 | 250 | 8,400 | 19,944 | 20.2 K to 19.9 K (-1.24 %) |
Oct 07 2014 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | President, Intl and ... | Sell | S | 34.13 | 3,750 | 127,983 | 101,534 | 105.3 K to 101.5 K (-3.56 %) |
Sep 26 2014 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | President, Intl and ... | Option Exercise | M | 8.14 | 14,923 | 121,473 | 14,923 | |
Sep 26 2014 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | President, Intl and ... | Sell | S | 36.00 | 14,923 | 537,228 | 105,284 | 120.2 K to 105.3 K (-12.41 %) |
Sep 26 2014 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | President, Intl and ... | Buy | M | 8.14 | 14,923 | 121,473 | 120,207 | 105.3 K to 120.2 K (+14.17 %) |
Aug 29 2014 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | President, Intl and ... | Option Exercise | M | 8.14 | 14,923 | 121,473 | 29,846 | |
Aug 29 2014 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | President, Intl and ... | Sell | S | 33.00 | 14,923 | 492,459 | 105,284 | 120.2 K to 105.3 K (-12.41 %) |
Aug 29 2014 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | President, Intl and ... | Buy | M | 8.14 | 14,923 | 121,473 | 120,207 | 105.3 K to 120.2 K (+14.17 %) |
Jun 09 2014 | ACOR | ACORDA THERAPEUTIC ... | SMITH IAN F | Director | Option Exercise | A | 34.96 | 10,000 | 349,600 | 10,000 | |
Jun 09 2014 | ACOR | ACORDA THERAPEUTIC ... | RAUSCHER STEVEN M | Director | Option Exercise | A | 34.96 | 10,000 | 349,600 | 10,000 | |
Jun 09 2014 | ACOR | ACORDA THERAPEUTIC ... | Randall Lorin | Director | Option Exercise | A | 34.96 | 10,000 | 349,600 | 10,000 | |
Jun 09 2014 | ACOR | ACORDA THERAPEUTIC ... | PANEM SANDRA PHD | Director | Option Exercise | A | 34.96 | 10,000 | 349,600 | 10,000 | |
Jun 09 2014 | ACOR | ACORDA THERAPEUTIC ... | Kelley John P | Director | Option Exercise | A | 34.96 | 10,000 | 349,600 | 10,000 | |
Jun 09 2014 | ACOR | ACORDA THERAPEUTIC ... | Jensen Peder | Director | Option Exercise | A | 34.96 | 10,000 | 349,600 | 10,000 | |
Jun 09 2014 | ACOR | ACORDA THERAPEUTIC ... | Greene Barry E | Director | Option Exercise | A | 34.96 | 10,000 | 349,600 | 10,000 | |
May 15 2014 | ACOR | ACORDA THERAPEUTIC ... | Hindman Andrew A. | Chief Business Dev. ... | Option Exercise | A | 30.35 | 27,768 | 842,759 | 27,768 | |
May 15 2014 | ACOR | ACORDA THERAPEUTIC ... | Hindman Andrew A. | Chief Business Dev. ... | Option Exercise | A | 30.35 | 138,840 | 4,213,794 | 138,840 | |
May 15 2014 | ACOR | ACORDA THERAPEUTIC ... | Hindman Andrew A. | Chief Business Dev. ... | Grant | A | 0.00 | 9,256 | 0 | 55,536 | 46.3 K to 55.5 K (+20.00 %) |
May 15 2014 | ACOR | ACORDA THERAPEUTIC ... | Hindman Andrew A. | Chief Business Dev. ... | Grant | A | 0.00 | 46,280 | 0 | 46,280 | 0 to 46.3 K |
Mar 07 2014 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | President, Intl and ... | Option Exercise | A | 39.38 | 46,750 | 1,841,015 | 46,750 | |
Mar 07 2014 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | President, Intl and ... | Grant | A | 0.00 | 8,250 | 0 | 105,284 | 97 K to 105.3 K (+8.50 %) |
Mar 07 2014 | ACOR | ACORDA THERAPEUTIC ... | Sabella Lauren M | Exec. VP-Commercial ... | Option Exercise | A | 39.38 | 34,000 | 1,338,920 | 34,000 | |
Mar 07 2014 | ACOR | ACORDA THERAPEUTIC ... | Sabella Lauren M | Exec. VP-Commercial ... | Grant | A | 0.00 | 6,000 | 0 | 18,403 | 12.4 K to 18.4 K (+48.38 %) |
Mar 07 2014 | ACOR | ACORDA THERAPEUTIC ... | ROGERS MICHAEL W | Chief Financial Off ... | Option Exercise | A | 39.38 | 10,396 | 409,394 | 10,396 | |
Mar 07 2014 | ACOR | ACORDA THERAPEUTIC ... | ROGERS MICHAEL W | Chief Financial Off ... | Grant | A | 0.00 | 1,835 | 0 | 47,435 | 45.6 K to 47.4 K (+4.02 %) |
Mar 07 2014 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief of Business O ... | Option Exercise | A | 39.38 | 34,000 | 1,338,920 | 34,000 | |
Mar 07 2014 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief of Business O ... | Grant | A | 0.00 | 6,000 | 0 | 20,194 | 14.2 K to 20.2 K (+42.27 %) |
Mar 07 2014 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Option Exercise | A | 39.38 | 100,789 | 3,969,071 | 100,789 | |
Mar 07 2014 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Grant | A | 0.00 | 17,786 | 0 | 478,529 | 460.7 K to 478.5 K (+3.86 %) |
Mar 07 2014 | ACOR | ACORDA THERAPEUTIC ... | Carrazana Enrique J. | Chief Medical Offic ... | Option Exercise | A | 39.38 | 37,400 | 1,472,812 | 37,400 | |
Mar 07 2014 | ACOR | ACORDA THERAPEUTIC ... | Carrazana Enrique J. | Chief Medical Offic ... | Grant | A | 0.00 | 6,600 | 0 | 39,127 | 32.5 K to 39.1 K (+20.29 %) |
Mar 07 2014 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientifc Off ... | Option Exercise | A | 39.38 | 34,000 | 1,338,920 | 34,000 | |
Mar 07 2014 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientifc Off ... | Grant | A | 0.00 | 6,000 | 0 | 65,787 | 59.8 K to 65.8 K (+10.04 %) |
Dec 09 2013 | ACOR | ACORDA THERAPEUTIC ... | Sabella Lauren M | Exec. VP-Commercial ... | Sell | S | 31.81 | 8,797 | 279,830 | 12,403 | 21.2 K to 12.4 K (-41.50 %) |
Dec 04 2013 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientifc Off ... | Sell | S | 33.51 | 9,088 | 304,563 | 59,787 | 68.9 K to 59.8 K (-13.19 %) |
Dec 04 2013 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | President, Intl and ... | Sell | S | 33.52 | 8,425 | 282,394 | 97,034 | 105.5 K to 97 K (-7.99 %) |
Dec 04 2013 | ACOR | ACORDA THERAPEUTIC ... | Sabella Lauren M | Exec. VP-Commercial ... | Sell | S | 33.52 | 6,603 | 221,319 | 21,200 | 27.8 K to 21.2 K (-23.75 %) |
Dec 04 2013 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief of Business O ... | Sell | S | 33.51 | 10,836 | 363,141 | 14,194 | 25 K to 14.2 K (-43.29 %) |
Dec 04 2013 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 33.52 | 18,125 | 607,468 | 460,743 | 478.9 K to 460.7 K (-3.78 %) |
Nov 25 2013 | ACOR | ACORDA THERAPEUTIC ... | Sabella Lauren M | Exec. VP-Commercial ... | Sell | S | 33.72 | 10,949 | 369,206 | 27,803 | 38.8 K to 27.8 K (-28.25 %) |
Dec 04 2013 | ACOR | ACORDA THERAPEUTIC ... | Carrazana Enrique J. | Chief Medical Offic ... | Sell | S | 33.56 | 1,640 | 55,034 | 32,527 | 34.2 K to 32.5 K (-4.80 %) |
Oct 17 2013 | ACOR | ACORDA THERAPEUTIC ... | Carrazana Enrique J. | Chief Medical Offic ... | Sell | S | 32.38 | 3,333 | 107,918 | 34,167 | 37.5 K to 34.2 K (-8.89 %) |
Oct 09 2013 | ACOR | ACORDA THERAPEUTIC ... | ROGERS MICHAEL W | Chief Financial Off ... | Option Exercise | A | 35.91 | 136,900 | 4,916,079 | 136,900 | |
Oct 09 2013 | ACOR | ACORDA THERAPEUTIC ... | ROGERS MICHAEL W | Chief Financial Off ... | Grant | A | 0.00 | 45,600 | 0 | 45,600 | 0 to 45.6 K |
Oct 09 2013 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief of Business O ... | Grant | A | 0.00 | 1,000 | 0 | 25,030 | 24 K to 25 K (+4.16 %) |
Oct 07 2013 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | President, Intl and ... | Sell | S | 35.74 | 3,750 | 134,009 | 105,459 | 109.2 K to 105.5 K (-3.43 %) |
Aug 20 2013 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Option Exercise | M | 2.60 | 8,176 | 21,258 | 0 | |
Aug 20 2013 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Option Exercise | M | 2.60 | 113,141 | 294,167 | 0 | |
Aug 20 2013 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Option Exercise | M | 2.60 | 19,461 | 50,599 | 0 | |
Aug 20 2013 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Option Exercise | M | 2.60 | 31,945 | 83,057 | 113,141 | |
Aug 20 2013 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Option Exercise | M | 2.60 | 55,993 | 145,582 | 145,086 | |
Aug 20 2013 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Option Exercise | M | 2.60 | 42,062 | 109,361 | 201,079 | |
Aug 20 2013 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Option Exercise | M | 2.60 | 19,000 | 49,400 | 19,461 | |
Aug 20 2013 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Buy | M | 2.60 | 8,176 | 21,258 | 478,868 | 470.7 K to 478.9 K (+1.74 %) |
Aug 20 2013 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Buy | M | 2.60 | 113,141 | 294,167 | 470,692 | 357.6 K to 470.7 K (+31.64 %) |
Aug 20 2013 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Buy | M | 2.60 | 19,461 | 50,599 | 357,551 | 338.1 K to 357.6 K (+5.76 %) |
Aug 20 2013 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 34.82 | 5,840 | 203,349 | 338,090 | 343.9 K to 338.1 K (-1.70 %) |
Aug 20 2013 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 34.25 | 26,105 | 894,096 | 343,930 | 370 K to 343.9 K (-7.05 %) |
Aug 20 2013 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Buy | M | 2.60 | 31,945 | 83,057 | 370,035 | 338.1 K to 370 K (+9.45 %) |
Aug 20 2013 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 34.02 | 55,993 | 1,904,882 | 338,090 | 394.1 K to 338.1 K (-14.21 %) |
Aug 20 2013 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Buy | M | 2.60 | 55,993 | 145,582 | 394,083 | 338.1 K to 394.1 K (+16.56 %) |
Aug 20 2013 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 34.04 | 61,062 | 2,078,550 | 338,090 | 399.2 K to 338.1 K (-15.30 %) |
Aug 20 2013 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Buy | M | 2.60 | 42,062 | 109,361 | 399,152 | 357.1 K to 399.2 K (+11.78 %) |
Aug 20 2013 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Buy | M | 2.60 | 19,000 | 49,400 | 357,090 | 338.1 K to 357.1 K (+5.62 %) |
Aug 06 2013 | ACOR | ACORDA THERAPEUTIC ... | Kelley John P | Director | Option Exercise | M | 16.74 | 15,000 | 251,100 | 10,000 | |
Aug 06 2013 | ACOR | ACORDA THERAPEUTIC ... | Kelley John P | Director | Sell | S | 38.00 | 15,000 | 570,000 | 0 | 15 K to 0 (-100.00 %) |
Aug 06 2013 | ACOR | ACORDA THERAPEUTIC ... | Kelley John P | Director | Buy | M | 16.74 | 15,000 | 251,100 | 15,000 | 0 to 15 K |
Jul 23 2013 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientifc Off ... | Option Exercise | M | 2.60 | 19,296 | 50,170 | 0 | |
Jul 23 2013 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientifc Off ... | Sell | S | 37.82 | 19,296 | 729,775 | 68,875 | 88.2 K to 68.9 K (-21.88 %) |
Jul 23 2013 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientifc Off ... | Buy | M | 2.60 | 19,296 | 50,170 | 88,171 | 68.9 K to 88.2 K (+28.02 %) |
Jun 12 2013 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 34.15 | 11,000 | 375,650 | 338,090 | 349.1 K to 338.1 K (-3.15 %) |
Jun 03 2013 | ACOR | ACORDA THERAPEUTIC ... | SMITH IAN F | Director | Option Exercise | A | 33.97 | 10,000 | 339,700 | 10,000 | |
Jun 03 2013 | ACOR | ACORDA THERAPEUTIC ... | RAUSCHER STEVEN M | Director | Option Exercise | A | 33.97 | 10,000 | 339,700 | 10,000 | |
Jun 03 2013 | ACOR | ACORDA THERAPEUTIC ... | PANEM SANDRA PHD | Director | Option Exercise | A | 33.97 | 10,000 | 339,700 | 10,000 | |
Jun 03 2013 | ACOR | ACORDA THERAPEUTIC ... | Randall Lorin | Director | Option Exercise | A | 33.97 | 10,000 | 339,700 | 10,000 | |
Jun 03 2013 | ACOR | ACORDA THERAPEUTIC ... | Jensen Peder | Director | Option Exercise | A | 33.97 | 10,000 | 339,700 | 10,000 | |
Jun 03 2013 | ACOR | ACORDA THERAPEUTIC ... | Kelley John P | Director | Option Exercise | A | 33.97 | 10,000 | 339,700 | 10,000 | |
Jun 03 2013 | ACOR | ACORDA THERAPEUTIC ... | Greene Barry E | Director | Option Exercise | A | 33.97 | 10,000 | 339,700 | 10,000 | |
May 10 2013 | ACOR | ACORDA THERAPEUTIC ... | PANEM SANDRA PHD | Director | Option Exercise | M | 25.45 | 10,000 | 254,500 | 0 | |
May 10 2013 | ACOR | ACORDA THERAPEUTIC ... | PANEM SANDRA PHD | Director | Sell | S | 33.80 | 10,000 | 338,000 | 2,912 | 12.9 K to 2.9 K (-77.45 %) |
May 10 2013 | ACOR | ACORDA THERAPEUTIC ... | PANEM SANDRA PHD | Director | Buy | M | 25.45 | 10,000 | 254,500 | 12,912 | 2.9 K to 12.9 K (+343.41 %) |
Mar 08 2013 | ACOR | ACORDA THERAPEUTIC ... | Sabella Lauren M | Exec. VP-Commercial ... | Option Exercise | A | 30.46 | 40,235 | 1,225,558 | 40,235 | |
Mar 08 2013 | ACOR | ACORDA THERAPEUTIC ... | Sabella Lauren M | Exec. VP-Commercial ... | Grant | A | 0.00 | 7,100 | 0 | 38,752 | 31.7 K to 38.8 K (+22.43 %) |
Mar 08 2013 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | President, Intl and ... | Option Exercise | A | 30.46 | 63,793 | 1,943,135 | 63,793 | |
Mar 08 2013 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | President, Intl and ... | Grant | A | 0.00 | 11,258 | 0 | 109,209 | 98 K to 109.2 K (+11.49 %) |
Mar 08 2013 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Option Exercise | A | 30.46 | 34,527 | 1,051,692 | 34,527 | |
Mar 08 2013 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Grant | A | 0.00 | 6,093 | 0 | 24,030 | 17.9 K to 24 K (+33.97 %) |
Mar 08 2013 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Option Exercise | A | 30.46 | 127,500 | 3,883,650 | 127,500 | |
Mar 08 2013 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Grant | A | 0.00 | 22,500 | 0 | 349,090 | 326.6 K to 349.1 K (+6.89 %) |
Mar 08 2013 | ACOR | ACORDA THERAPEUTIC ... | Carrazana Enrique J. | Chief Medical Offic ... | Option Exercise | A | 30.46 | 47,035 | 1,432,686 | 47,035 | |
Mar 08 2013 | ACOR | ACORDA THERAPEUTIC ... | Carrazana Enrique J. | Chief Medical Offic ... | Grant | A | 0.00 | 8,300 | 0 | 37,500 | 29.2 K to 37.5 K (+28.42 %) |
Mar 08 2013 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientifc Off ... | Option Exercise | A | 30.46 | 42,785 | 1,303,231 | 42,785 | |
Mar 08 2013 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientifc Off ... | Grant | A | 0.00 | 7,550 | 0 | 68,875 | 61.3 K to 68.9 K (+12.31 %) |
Dec 11 2012 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Option Exercise | M | 5.85 | 1 | 6 | 21,499 | |
Dec 11 2012 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Buy | M | 5.85 | 1 | 6 | 17,937 | 17.9 K to 17.9 K (+0.01 %) |
Dec 05 2012 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 24.21 | 9,313 | 225,438 | 17,936 | 27.2 K to 17.9 K (-34.18 %) |
Dec 05 2012 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientifc Off ... | Sell | S | 24.20 | 7,200 | 174,244 | 61,325 | 68.5 K to 61.3 K (-10.51 %) |
Dec 05 2012 | ACOR | ACORDA THERAPEUTIC ... | Sabella Lauren M | Exec. VP-Commercial ... | Sell | S | 24.58 | 4,364 | 107,259 | 31,652 | 36 K to 31.7 K (-12.12 %) |
Dec 05 2012 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | President, Intl and ... | Sell | S | 24.20 | 7,019 | 169,868 | 97,951 | 105 K to 98 K (-6.69 %) |
Dec 05 2012 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 24.22 | 16,407 | 397,415 | 326,590 | 343 K to 326.6 K (-4.78 %) |
Dec 05 2012 | ACOR | ACORDA THERAPEUTIC ... | Carrazana Enrique J. | Chief Medical Offic ... | Sell | S | 24.50 | 800 | 19,600 | 29,200 | 30 K to 29.2 K (-2.67 %) |
Nov 30 2012 | ACOR | ACORDA THERAPEUTIC ... | Randall Lorin | Director | Option Exercise | M | 6.00 | 10,198 | 61,188 | 0 | |
Nov 30 2012 | ACOR | ACORDA THERAPEUTIC ... | Randall Lorin | Director | Sell | S | 24.70 | 10,198 | 251,901 | 0 | 10.2 K to 0 (-100.00 %) |
Nov 30 2012 | ACOR | ACORDA THERAPEUTIC ... | Randall Lorin | Director | Buy | M | 6.00 | 10,198 | 61,188 | 10,198 | 0 to 10.2 K |
Nov 15 2012 | ACOR | ACORDA THERAPEUTIC ... | PANEM SANDRA PHD | Director | Option Exercise | M | 20.16 | 10,000 | 201,600 | 0 | |
Nov 15 2012 | ACOR | ACORDA THERAPEUTIC ... | PANEM SANDRA PHD | Director | Option Exercise | M | 18.21 | 10,000 | 182,100 | 0 | |
Nov 15 2012 | ACOR | ACORDA THERAPEUTIC ... | PANEM SANDRA PHD | Director | Option Exercise | M | 18.65 | 1,287 | 24,003 | 0 | |
Nov 15 2012 | ACOR | ACORDA THERAPEUTIC ... | PANEM SANDRA PHD | Director | Option Exercise | M | 12.48 | 1,282 | 15,999 | 0 | |
Nov 15 2012 | ACOR | ACORDA THERAPEUTIC ... | PANEM SANDRA PHD | Director | Sell | S | 24.12 | 21,287 | 513,442 | 2,912 | 24.2 K to 2.9 K (-87.97 %) |
Nov 15 2012 | ACOR | ACORDA THERAPEUTIC ... | PANEM SANDRA PHD | Director | Buy | M | 20.16 | 10,000 | 201,600 | 24,199 | 14.2 K to 24.2 K (+70.43 %) |
Nov 15 2012 | ACOR | ACORDA THERAPEUTIC ... | PANEM SANDRA PHD | Director | Buy | M | 18.21 | 10,000 | 182,100 | 14,199 | 4.2 K to 14.2 K (+238.15 %) |
Nov 15 2012 | ACOR | ACORDA THERAPEUTIC ... | PANEM SANDRA PHD | Director | Buy | M | 18.65 | 1,287 | 24,003 | 4,199 | 2.9 K to 4.2 K (+44.20 %) |
Nov 15 2012 | ACOR | ACORDA THERAPEUTIC ... | PANEM SANDRA PHD | Director | Sell | S | 24.11 | 1,282 | 30,909 | 2,912 | 4.2 K to 2.9 K (-30.57 %) |